Pfizer
Article
Pfizer is a recurring brand in the Astral Codex Ten archive, appearing 2 times across 2 issues between January 04, 2022 and May 18, 2022. The archive places it in contexts such as “Pfizer’s vaccine is safe”; “gotten money from Pfizer”. It most often appears alongside ADHD, AGI, America.
Metadata
- Category: Brands
- Mention count: 2
- Issue count: 2
- First seen: January 04, 2022
- Last seen: May 18, 2022
Appears In
Related Pages
-
- ADHD (1 shared issues)
-
- AGI (1 shared issues)
-
- America (1 shared issues)
-
- Angelini (1 shared issues)
-
- AOP Orphan Pharmaceuticals AG (1 shared issues)
-
- Asian Scientist (1 shared issues)
-
- AstraZeneca (1 shared issues)
-
- Behind the Curve (1 shared issues)
-
- benzodiazepines (1 shared issues)
-
- benzos (1 shared issues)
-
- buspirone (1 shared issues)
-
- Carlat (1 shared issues)
External Links
Source Context
Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.
But apply it to COVID, and it’s even worse. Dr. Fauci and the CDC tell me every day that Pfizer’s vaccine is safe - but Male Scientist and NASA told their victims every day that Tech Company’s comet retrieval plan was safe. Sounds like we can’t trust scientific authorities when there might be a profit motive involved, better skip the jab! I hear ivermectin looks promising…
Professor Kasper seems like as legitimate and respectable a researcher as you can get for these kinds of things: head of the Department of Psychiatry at the University of Vienna, chair of the World Psychiatric Association’s pharmacology branch, editor of three good journals, various important and influential papers. Sure, he’s gotten “grants/research support, consulting fees and/or honoraria” from Schwabe. But he’s also gotten money from “Angelini, AOP Orphan Pharmaceuticals AG, AstraZeneca, Eli Lilly, Janssen, KRKA-Pharma, Lundbeck, Neuraxpharm, Pfizer, Pierre Fabre . . . and Servier”, and you don’t see him writing nearly as many glowing papers about their drugs. High-level academic psychiatrists academics are usually working with a bunch of drug companies and getting paid for that work, and this isn’t usually considered disqualifying to their credibility.
Inline links: Professor Kasper